The Attitude of People in Anambra State, Nigeria towards COVID-19 Vaccination

Abraham Onyedinefu; Ignatius Nwankwo

doi:10.58421/misro.v3i1.181

DOI:

https://doi.org/10.58421/misro.v3i1.181

Authors

Abraham Onyedinefu Nnamdi Azikiwe University https://orcid.org/0009-0004-6739-8786
Ignatius Nwankwo Nnamdi Azikiwe University

Keywords:

Attitude, COVID-19, Pandemic, Vaccination, Vaccine Hesitancy, Virus

Abstract

This work investigated people's attitudes towards COVID-19 vaccination in the Anambra state, Nigeria. The 5C Model of Vaccination was adopted as the theoretical framework. The study adopted a mixed methods research design, using the multi-stage sampling procedure in selecting 378 respondents. A structured questionnaire and In-Depth Interview (IDI) guide served as instruments for data collection. The quantitative data were analysed using the Statistical Package for Social Sciences (SPSS) version 21, while the qualitative data were analysed using manual content analysis. One research hypothesis was formulated and tested using chi-square inferential statistics. The study found a negative attitude towards COVID-19 vaccination in Anambra state, Nigeria. The study recommended that the government, health workers, and NGOs work cooperatively to enlighten the public on the importance of accepting COVID-19 vaccination.

Downloads

Download data is not yet available.

Author Biographies

Abraham Onyedinefu, Nnamdi Azikiwe University

Graduate Assistant, Department of Sociology/Anthropology, Nnamdi Azikiwe University, Awka.

Ignatius Nwankwo, Nnamdi Azikiwe University

Professor of Medical Sociology, Department of Sociology/Anthropology, Nnamdi Azikiwe University, Awka.

References

L. I. Anorue, A. C. Ugwu, S. U. Ugboaja, U. O. Nwabunze, C. C. Ugwulor-Onyinyechi, and C. Njoku, “Communicating COVID-19 Vaccine Safety: Knowledge and Attitude Among Residents of South East, Nigeria,” Infect. Drug Resist., vol. Volume 14, pp. 3785–3794, Sep. 2021, doi: 10.2147/IDR.S329183.

M. A. Shereen, S. Khan, A. Kazmi, N. Bashir, and R. Siddique, “COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses,” J. Adv. Res., vol. 24, pp. 91–98, Jul. 2020, doi: 10.1016/j.jare.2020.03.005.

O. . Moronkola, A. . Iyanda, O. . Moronkola, and O. Abiola, “A qualitative study on perception, attitude, and apathy towards non-pharmaceutical precautionary measures against COVID-19 among residents of Ibadan, Nigeria,” Afr. J. Health Sci., vol. 33, no. 6, pp. 35–43, 2020.

R. Keni, A. Alexander, P. G. Nayak, J. Mudgal, and K. Nandakumar, “COVID-19: Emergence, Spread, Possible Treatments, and Global Burden,” Front. Public Heal., vol. 8, 2020, doi: 10.3389/fpubh.2020.00216.

A. Haleem, M. Javaid, and R. Vaishya, “Effects of COVID-19 pandemic in daily life,” Curr. Med. Res. Pract., vol. 10, no. 2, pp. 78–79, Mar. 2020, doi: 10.1016/j.cmrp.2020.03.011.

U.S. Department of Health and Human Services, COVID-19 Vaccination Field Guide: 12 Strategies for Your Community. U.S. Department of Health and Human Services, 2021.

I. Ayouni et al., “Effective public health measures to mitigate the spread of COVID-19: a systematic review,” BMC Public Health, vol. 21, no. 1, p. 1015, Dec. 2021, doi: 10.1186/s12889-021-11111-1.

S. Lai et al., “Effect of non-pharmaceutical interventions to contain COVID-19 in China,” Nature, vol. 585, no. 7825, pp. 410–413, Sep. 2020, doi: 10.1038/s41586-020-2293-x.

S. Iezadi et al., “Effectiveness of non-pharmaceutical public health interventions against COVID-19: A systematic review and meta-analysis,” PLoS One, vol. 16, no. 11, p. e0260371, Nov. 2021, doi: 10.1371/journal.pone.0260371.

M. Daly, A. Jones, and E. Robinson, “Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021,” JAMA, vol. 325, no. 23, p. 2397, Jun. 2021, doi: 10.1001/jama.2021.8246.

WHO, “Covid-19 vaccines,” 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines (accessed Jan. 23, 2022).

A. J. Pollard and E. M. Bijker, “A guide to vaccinology: from basic principles to new developments,” Nat. Rev. Immunol., vol. 21, no. 2, pp. 83–100, Feb. 2021, doi: 10.1038/s41577-020-00479-7.

H. Ledford, “What the immune response to the coronavirus says about the prospects for a vaccine,” Nature, vol. 585, no. 7823, pp. 20–21, Sep. 2020, doi: 10.1038/d41586-020-02400-7.

C. M. C. Rodrigues and S. A. Plotkin, “Impact of Vaccines; Health, Economic and Social Perspectives,” Front. Microbiol., vol. 11, Jul. 2020, doi: 10.3389/fmicb.2020.01526.

UNICEF, “What are vaccines?,” 2021. https://www.unicef.org/armenia/en/stories/what-are-vaccines (accessed Sep. 21, 2023).

A. S. Oyekale, “Compliance Indicators of COVID-19 Prevention and Vaccines Hesitancy in Kenya: A Random-Effects Endogenous Probit Model,” Vaccines, vol. 9, no. 11, p. 1359, Nov. 2021, doi: 10.3390/vaccines9111359.

U. A. Eze et al., “Determinants for Acceptance of COVID-19 Vaccine in Nigeria,” Cureus, Nov. 2021, doi: 10.7759/cureus.19801.

A. A. Ebonyi and A. Abok, “Sociological Assessment of the Perception of Nigerians on the Coronavirus disease (Covid-19) Pandemic,” Int. J. Res. Sci. Innov., vol. VII, no. V, pp. 192–198, 2020.

C. N. Obi-Ezeani et al., “Knowledge, perception and willingness to receive the current COVID-19 vaccine among residents of Awka metropolis, Anambra State, Nigeria,” Int. J. Res. Med. Sci., vol. 9, no. 11, p. 3243, Oct. 2021, doi: 10.18203/2320-6012.ijrms20214405.

A. Lewis, “6 Things to Know About How Nigeria Is Distributing the COVID-19 Vaccine,” 2021. https://www.globalcitizen.org/en/content/things-to-know-nigeria-covid-vaccine-distribution/ (accessed Feb. 17, 2022).

W. G. Cochran, Sampling Technique, 2nd ed. New York: John Wiley, 1963.

J. W. Creswell and V. L. P. Clark, “Choosing a mixed methods design,” in Designing and Conducting Mixed Methods Research, California: Sage Publications, Inc., 2011, pp. 53–106.

B. M. Beg et al., “Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan,” PLoS One, vol. 17, no. 3, p. e0266028, Mar. 2022, doi: 10.1371/journal.pone.0266028.

B. C. James et al., “Attitudes and perceptions of Nigerians regarding receiving COVID-19 vaccines: an online cross-sectional study.,” Pan Afr. Med. J., vol. 41, p. 247, 2022, doi: 10.11604/pamj.2022.41.247.33286.

P. O. Olapegba et al., “Survey data of COVID-19-related Knowledge, Risk Perceptions and Precautionary Behavior among Nigerians,” Data Br., vol. 30, p. 105685, Jun. 2020, doi: 10.1016/j.dib.2020.105685.

S. H. Hassan, “Supporting Vaccine Logistics and Maintaining the Cold Chain in Northern Nigeria,” 2020. https://www.ehealthafrica.org/blog/2020/6/17/supporting-vaccine-logistics-and-maintaining-the-cold-chain-in-northern-nigeria (accessed Feb. 17, 2022).

O. Ilesanmi and A. Afolabi, “Perception and practices during the COVID-19 pandemic in an urban community in Nigeria: a cross-sectional study,” PeerJ, vol. 8, p. e10038, Sep. 2020, doi: 10.7717/peerj.10038.

H. Abebe, S. Shitu, and A. Mose, “Understanding of COVID-19 Vaccine Knowledge, Attitude, Acceptance, and Determinates of COVID-19 Vaccine Acceptance Among Adult Population in Ethiopia,” Infect. Drug Resist., vol. Volume 14, pp. 2015–2025, Jun. 2021, doi: 10.2147/IDR.S312116.